Behçet's disease (BD) is a systemic large-vessel vasculitis characterized by a wide clinical spectrum including recurrent oral and genital ulcerations, uveitis, and vascular, neurological ...
For the research, Ruhl and her team studied 97 patients with sickle cell disease who underwent a low-intensity, or non-myeloablative, blood stem cell transplant between 2004–2019 at the NIH's ...
Reduced-intensity conditioning regimes for HSCT candidates have similar short-term outcomes as HSCT candidates receiving myeloablative conditioning. Partial HLA-matched cord blood is a viable stem ...
However, the patient was pending allo-HSCT with BU/FLU/Cy/ATG as the myeloablative conditioning regimen for the second time, accompanied by a large amount of transfusion and probable GVHD. Despite the ...
He is also working to reduce toxicities and maximize the cancer-killing powers of transplanted immune cells. One of Dr. Storb’s major scientific contributions is the non-myeloablative transplant.
Patients with severe internal organ involvement were excluded (table 1). The first RCT was the American Scleroderma Stem cell versus Immune Suppression Trial (ASSIST), a phase II trial comparing ...
The authors present a case of acyclovir-resistant HSV reactivation in a 26-year-old woman 7 days post T-deplete sibling allograft on a background of combined cyclophosphamide and total body ...